Keywords: genzyme, sunway, sign, pah, drug, deal, biotechnology

Genzyme and Sunway sign PAH drug deal

Article | 05 November 2007

US biotechnology firm Genzyme and Shanghai-headquartered Sunway Biotech have signed an agreement to develop and commercialize the former's experimental gene ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in